Mrinal M. Gounder

20.3k total citations
164 papers, 3.7k citations indexed

About

Mrinal M. Gounder is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Mrinal M. Gounder has authored 164 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Pulmonary and Respiratory Medicine, 78 papers in Oncology and 43 papers in Molecular Biology. Recurrent topics in Mrinal M. Gounder's work include Sarcoma Diagnosis and Treatment (68 papers), Soft tissue tumor case studies (25 papers) and CAR-T cell therapy research (20 papers). Mrinal M. Gounder is often cited by papers focused on Sarcoma Diagnosis and Treatment (68 papers), Soft tissue tumor case studies (25 papers) and CAR-T cell therapy research (20 papers). Mrinal M. Gounder collaborates with scholars based in United States, Germany and Canada. Mrinal M. Gounder's co-authors include William D. Tap, Mary Louise Keohan, Sandra P. D’Angelo, Mark A. Dickson, Gary K. Schwartz, Li‐Xuan Qin, Cristina R. Antonescu, Samuel Singer, Robert G. Maki and Aimeé M. Crago and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Mrinal M. Gounder

155 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mrinal M. Gounder United States 31 1.9k 1.8k 1.1k 648 528 164 3.7k
Sandra J. Strauss United Kingdom 30 1.3k 0.7× 1.5k 0.8× 844 0.8× 579 0.9× 420 0.8× 94 3.1k
Maud Toulmonde France 23 1.2k 0.7× 1.3k 0.7× 689 0.6× 391 0.6× 265 0.5× 113 2.5k
Federica Grosso Italy 33 1.8k 1.0× 3.0k 1.7× 642 0.6× 395 0.6× 633 1.2× 158 4.4k
Mary Louise Keohan United States 34 2.2k 1.2× 2.8k 1.5× 673 0.6× 738 1.1× 718 1.4× 105 4.4k
Arthur P. Staddon United States 29 1.4k 0.8× 2.4k 1.3× 652 0.6× 426 0.7× 1.1k 2.1× 67 3.5k
David R. D’Adamo United States 30 2.6k 1.4× 3.2k 1.7× 824 0.8× 742 1.1× 980 1.9× 65 4.9k
Isabelle Hostein France 33 1.0k 0.6× 2.5k 1.3× 791 0.7× 836 1.3× 859 1.6× 61 3.7k
Brian L. Samuels United States 29 1.7k 0.9× 2.2k 1.2× 497 0.5× 570 0.9× 526 1.0× 74 3.4k
Isabelle Ray‐Coquard France 27 2.1k 1.1× 2.8k 1.5× 729 0.7× 718 1.1× 317 0.6× 73 3.8k
Antonio López–Pousa Spain 32 1.7k 0.9× 1.9k 1.0× 541 0.5× 366 0.6× 280 0.5× 161 3.4k

Countries citing papers authored by Mrinal M. Gounder

Since Specialization
Citations

This map shows the geographic impact of Mrinal M. Gounder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mrinal M. Gounder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mrinal M. Gounder more than expected).

Fields of papers citing papers by Mrinal M. Gounder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mrinal M. Gounder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mrinal M. Gounder. The network helps show where Mrinal M. Gounder may publish in the future.

Co-authorship network of co-authors of Mrinal M. Gounder

This figure shows the co-authorship network connecting the top 25 collaborators of Mrinal M. Gounder. A scholar is included among the top collaborators of Mrinal M. Gounder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mrinal M. Gounder. Mrinal M. Gounder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cameron, Daniel, Nadia Zaffaroni, Noemi Arrighetti, et al.. (2025). Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas. Journal of Clinical Investigation. 135(20).
2.
Ratan, Ravin, Bernd Kasper, Thierry Alcindor, et al.. (2025). Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial. Journal of Clinical Oncology. 43(34). 3646–3651.
3.
Kelly, Ciara M., Mary Louise Keohan, Jason E. Chan, et al.. (2024). 1752P A retrospective single-center study of outcomes to immune checkpoint blockade-based therapy in leiomyosarcoma. Annals of Oncology. 35. S1045–S1045. 1 indexed citations
4.
5.
Dickson, Mark A., Sujana Movva, Ciara M. Kelly, et al.. (2024). 1720MO A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma. Annals of Oncology. 35. S1031–S1031. 4 indexed citations
6.
Gounder, Mrinal M., et al.. (2023). Abstract CT070: Double-blind placebo-controlled trial of AL102 for treatment of progressing desmoid tumors: the RINGSIDE phase 3 study design. Cancer Research. 83(8_Supplement). CT070–CT070. 1 indexed citations
7.
LoRusso, Patricia, Noboru Yamamoto, Manish R. Patel, et al.. (2023). The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study. Cancer Discovery. 13(8). 1802–1813. 55 indexed citations
8.
Rosenbaum, Evan, Kenneth Seier, Martina Bradić, et al.. (2023). Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas. Cancer Research Communications. 3(10). 2118–2125. 6 indexed citations
9.
Spolverato, Gaya, Giulia Capelli, Bernd Kasper, & Mrinal M. Gounder. (2022). Management of Desmoid Tumors. Surgical Oncology Clinics of North America. 31(3). 447–458. 2 indexed citations
10.
Gounder, Mrinal M., Albiruni R. Abdul Razak, Adrienne M. Gilligan, et al.. (2021). Health-Related Quality of Life and Pain with Selinexor in Patients with Advanced Dedifferentiated Liposarcoma. Future Oncology. 17(22). 2923–2939. 13 indexed citations
11.
Rosenbaum, Evan, Kenneth Seier, Chaitanya Bandlamudi, et al.. (2020). HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome. Clinical Cancer Research. 26(20). 5448–5455. 12 indexed citations
12.
Gounder, Mrinal M., Priscilla Merriam, Ravin Ratan, et al.. (2020). Real‐world outcomes of patients with locally advanced or metastatic epithelioid sarcoma. Cancer. 127(8). 1311–1317. 12 indexed citations
13.
Gounder, Mrinal M., Guo Zhu, Eric Lis, et al.. (2019). Immunologic Correlates of the Abscopal Effect in a SMARCB1/INI1-negative Poorly Differentiated Chordoma after EZH2 Inhibition and Radiotherapy. Clinical Cancer Research. 25(7). 2064–2071. 61 indexed citations
14.
Gounder, Mrinal M., David M. Thomas, & William D. Tap. (2017). Locally Aggressive Connective Tissue Tumors. Journal of Clinical Oncology. 36(2). 202–209. 42 indexed citations
15.
D’Angelo, Sandra P., Alexander N. Shoushtari, Mary Louise Keohan, et al.. (2016). Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab. Clinical Cancer Research. 23(12). 2972–2980. 98 indexed citations
16.
Shoushtari, Alexander N., Jonathan Landa, Deborah Kuk, et al.. (2016). Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma. Sarcoma. 2016. 1–8. 11 indexed citations
17.
Eaton, Anne, Alexia Iasonos, Mrinal M. Gounder, et al.. (2015). Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated Toxicities. Clinical Cancer Research. 22(3). 553–559. 11 indexed citations
18.
Dickson, Mark A., William D. Tap, Mary Louise Keohan, et al.. (2013). Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4 -Amplified Well-Differentiated or Dedifferentiated Liposarcoma. Journal of Clinical Oncology. 31(16). 2024–2028. 317 indexed citations
19.
Iasonos, Alexia, Mrinal M. Gounder, David R. Spriggs, et al.. (2012). The Impact of Non–Drug-Related Toxicities on the Estimation of the Maximum Tolerated Dose in Phase I Trials. Clinical Cancer Research. 18(19). 5179–5187. 13 indexed citations
20.
Bharti, Ajit, Stine‐Kathrein Kraeft, Mrinal M. Gounder, et al.. (1998). Inactivation of DNA-Dependent Protein Kinase by Protein Kinase Cδ: Implications for Apoptosis. Molecular and Cellular Biology. 18(11). 6719–6728. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra J. Strauss Breakdown of academic impact, for papers by Maud Toulmonde Breakdown of academic impact, for papers by Federica Grosso Breakdown of academic impact, for papers by Mary Louise Keohan Breakdown of academic impact, for papers by Arthur P. Staddon Breakdown of academic impact, for papers by David R. D’Adamo Breakdown of academic impact, for papers by Isabelle Hostein Breakdown of academic impact, for papers by Brian L. Samuels Breakdown of academic impact, for papers by Isabelle Ray‐Coquard Breakdown of academic impact, for papers by Antonio López–Pousa
Rankless by CCL
2026